Bio-Rad Laboratories BIO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $532.2M+16.9% | $455.2M+21.4% | $374.9M+92.8% | $194.4M-71.0% | ||
| $157.6M-4.8% | $165.6M+5.7% | $156.7M+38.9% | $112.8M-15.7% | ||
| $669.3M-47.6% | $1.28B+85.3% | $689M-66.6% | $2.06B+142% | ||
| $793.6M-28.2% | $1.11B+120% | $501.9M-29.1% | $708.2M+66.4% | ||
| —— | —— | $200K0.0% | $200K+285% | ||
| -$189.7M-18.4% | -$160.2M-893% | $20.2M+102% | -$1.21B-51.4% | ||
| $295.5M+45.1% | $203.6M-52.5% | $428.7M+98.7% | $215.7M— | ||
| $500K+25.0% | $400K-20.0% | $500K0.0% | $500K-83.4% | ||
| $15.8M-17.7% | $19.2M+1.2% | $18.96M-6.9% | $20.38M+191% | ||
| -$286.5M-30.9% | -$218.8M+48.6% | -$425.6M— | —— | ||
| —— | $9.2M— | —— | —— | ||
| $42.4M— | —— | -$30.1M— | —— | ||
| $46.6M+0.2% | $46.5M-2.1% | $47.5M+94.7% | $24.4M+984% | ||
| $63.4M-36.2% | $99.4M-23.3% | $129.6M-18.1% | $158.3M+17.5% | ||
| $2.06B0.0% | $2.06B-8.1% | $2.24B-7.0% | $2.41B+13.2% | ||
| —— | —— | —— | —— | ||
| $2.66B+4.0% | $2.55B-4.9% | $2.68B-0.6% | $2.7B-6.5% | ||
| $81M-5.9% | $86.1M-14.0% | $100.1M+47.0% | $68.1M+93.0% | ||
| -$38.1M-290% | $20.1M+145% | $8.2M-53.4% | $17.6M+40.1% | ||
| $62M-68.9% | $199.3M-44.8% | $361.3M+1.0% | $357.8M+4.8% | ||
| $793.6M-28.2% | $1.11B+120% | $501.9M-29.1% | $708.2M+66.4% | ||
| —— | —— | $200K0.0% | $200K+285% | ||
| —— | —— | —— | —— | ||
| $15.8M-17.7% | $19.2M+3.8% | $18.5M+5.1% | $17.6M-14.7% | ||
| -$16.9M-284% | $9.2M+2,200% | $400K-86.7% | $3M+124% | ||
| $46.6M+0.2% | $46.5M-2.1% | $47.5M+94.7% | $24.4M+984% | ||
| $63.4M-36.2% | $99.4M-23.3% | $129.6M-18.1% | $158.3M+17.5% | ||
| $374.6M+29.4% | $289.6M+32.7% | $218.2M— | —— | ||
| $374.6M+29.4% | $289.6M+32.7% | $218.2M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Rad Laboratories generate?
- Bio-Rad Laboratories (BIO) generated $510.4M in operating cash flow over the trailing twelve months.
- What is Bio-Rad Laboratories's free cash flow?
- After $153.2M of capital expenditures, Bio-Rad Laboratories's free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
- Where does Bio-Rad Laboratories's cash flow data come from?
- Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
